Chemoradiation Treatment for Head and Neck Cancer

Summary

This is a Phase II study of cetuximab, carboplatin and radiotherapy (RT) in patients with Locally Advanced Head and Neck Carcinomas (LAHNC) who are unfit for cisplatin. The aim of this study is to show the feasibility and safety profile of the combination of cetuximab, carboplatin and RT in treatment of patients with LAHNC.

Timeline

Start

2008-04

Primary completion

2014-12

Completion

2015-12

Drugs

Indications